Karli Rosner

Summary

Affiliation: Wayne State University
Country: USA

Publications

  1. pmc Rad6 is a Potential Early Marker of Melanoma Development
    Karli Rosner
    Department of Dermatology, Wayne State University, 110, East Warren Avenue, Detroit, MI 48201 Center for Molecular Medicine and Genetics, Wayne State University, 110, East Warren Avenue, Detroit, MI 48201 Karmanos Cancer Institute, Wayne State University, 110, East Warren Avenue, Detroit, MI 48201 Electronic address
    Transl Oncol . 2014
  2. pmc WT1 marker is not sufficient for distinguishing between melanoma and melanocytic nevi
    Karli Rosner
    Laboratory for Molecular Dermatology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA
    J Cutan Pathol 36:1077-82. 2009
  3. doi request reprint Engineering a waste management enzyme to overcome cancer resistance to apoptosis: adding DNase1 to the anti-cancer toolbox
    K Rosner
    Laboratory for Molecular Dermatology, Program in Molecular Biology and Genetics, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA
    Cancer Gene Ther 18:346-57. 2011

Collaborators

Detail Information

Publications3

  1. pmc Rad6 is a Potential Early Marker of Melanoma Development
    Karli Rosner
    Department of Dermatology, Wayne State University, 110, East Warren Avenue, Detroit, MI 48201 Center for Molecular Medicine and Genetics, Wayne State University, 110, East Warren Avenue, Detroit, MI 48201 Karmanos Cancer Institute, Wayne State University, 110, East Warren Avenue, Detroit, MI 48201 Electronic address
    Transl Oncol . 2014
    ..These data suggest a role for Rad6 in melanoma pathogenesis and that Rad6 expression status may serve as an early marker for melanoma development...
  2. pmc WT1 marker is not sufficient for distinguishing between melanoma and melanocytic nevi
    Karli Rosner
    Laboratory for Molecular Dermatology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA
    J Cutan Pathol 36:1077-82. 2009
    ..For this reason, pathologists have sought after immunohistochemistry to assist with difficult cases. Recently, Wilms' tumor 1 protein (WT1) has been suggested to differentiate between melanoma and melanocytic nevi...
  3. doi request reprint Engineering a waste management enzyme to overcome cancer resistance to apoptosis: adding DNase1 to the anti-cancer toolbox
    K Rosner
    Laboratory for Molecular Dermatology, Program in Molecular Biology and Genetics, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA
    Cancer Gene Ther 18:346-57. 2011
    ..Coupled to different tissue-specific gene expression elements, this recombinant DNase1 may serve as a platform for eliminating a variety of cancer types...